曲妥珠单抗联合伊沙匹隆对晚期转移性乳腺癌患者的疗效及CEA、CA125、CA15-3水平的影响(3)
综上所述,曲妥珠单抗与伊沙匹隆联合使用治疗晚期MBC的效果较好,且安全性较高,并可降低CEA、CA125和CA15-3水平,值得在临床上推广。参考文献
[1]黄任平.曲妥珠单抗联合伊沙匹隆治疗晚期转移性乳腺癌的疗效观察[J].河北医学,2017,23(10):1958-1602.
[2] Yan H,Yu K,Zhang K,et al.Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC):a meta-analysis of randomized controlled trial[J].Oncotarget,2017,8(60):102458-102467.
[3]金雪瑛 ......
您现在查看是摘要页,全文长 3620 字符。